
Shares of telehealth platform Hims & Hers HIMS.N fall 5.1% to $44.72 in extended trading
The U.S. Federal Trade Commission is probing complaints about HIMS' advertising and cancellation practices, Bloomberg News reports, citing people familiar with the matter
The company previously said it was cooperating with an unspecified FTC investigation after the agency demanded information from the company in October 2023
Stock up 94.9% YTD